Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.

Alonso A, Jick SS, Olek MJ, Hernán MA.

J Neurol. 2007 Dec;254(12):1736-41. Epub 2007 Oct 1.

PMID:
17896096
2.

High incidence of post-lumbar puncture headaches in patients with multiple sclerosis treated with natalizumab: role of intrathecal leukocytes.

Stüve O, Cravens PD, Singh MP, Frohman EM, Phillips JT, Remington G, Hu W, Hemmer B, Olek MJ, Monson NL, Racke MK.

Arch Neurol. 2007 Jul;64(7):1055-6. No abstract available.

PMID:
17620501
3.

Diagnosis and management of multiple sclerosis: case studies.

Woo DA, Olek MJ, Frohman EM.

Neurol Clin. 2006 May;24(2):199-214.

PMID:
16684629
4.

Recent use of oral contraceptives and the risk of multiple sclerosis.

Alonso A, Jick SS, Olek MJ, Ascherio A, Jick H, Hernán MA.

Arch Neurol. 2005 Sep;62(9):1362-5.

PMID:
16157743
5.

Cigarette smoking and the progression of multiple sclerosis.

Hernán MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H.

Brain. 2005 Jun;128(Pt 6):1461-5. Epub 2005 Mar 9.

PMID:
15758034
6.

Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.

Hernán MA, Jick SS, Olek MJ, Jick H.

Neurology. 2004 Sep 14;63(5):838-42.

PMID:
15365133
7.

Vitamin D intake and incidence of multiple sclerosis.

Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A.

Neurology. 2004 Jan 13;62(1):60-5.

PMID:
14718698
8.

Infection with Chlamydia pneumoniae and risk of multiple sclerosis.

Munger KL, Peeling RW, Hernán MA, Chasan-Taber L, Olek MJ, Hankinson SE, Hunter D, Ascherio A.

Epidemiology. 2003 Mar;14(2):141-7.

PMID:
12606878
9.

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.

Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, Hankinson SE, Hunter DJ.

JAMA. 2001 Dec 26;286(24):3083-8.

PMID:
11754673
10.

Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women.

Zhang SM, Hernán MA, Olek MJ, Spiegelman D, Willett WC, Ascherio A.

Neurology. 2001 Jul 10;57(1):75-80.

PMID:
11445631
11.

Cigarette smoking and incidence of multiple sclerosis.

Hernán MA, Olek MJ, Ascherio A.

Am J Epidemiol. 2001 Jul 1;154(1):69-74.

PMID:
11427406
12.

Multiple sclerosis and age at infection with common viruses.

Hernán MA, Zhang SM, Lipworth L, Olek MJ, Ascherio A.

Epidemiology. 2001 May;12(3):301-6.

PMID:
11337603
13.

Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.

Sperling RA, Guttmann CR, Hohol MJ, Warfield SK, Jakab M, Parente M, Diamond EL, Daffner KR, Olek MJ, Orav EJ, Kikinis R, Jolesz FA, Weiner HL.

Arch Neurol. 2001 Jan;58(1):115-21.

PMID:
11176944
14.

Hepatitis B vaccination and the risk of multiple sclerosis.

Ascherio A, Zhang SM, Hernán MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM.

N Engl J Med. 2001 Feb 1;344(5):327-32.

15.

Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women.

Zhang SM, Willett WC, Hernán MA, Olek MJ, Ascherio A.

Am J Epidemiol. 2000 Dec 1;152(11):1056-64.

PMID:
11117615
16.

Oral contraceptives and the incidence of multiple sclerosis.

Hernán MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A.

Neurology. 2000 Sep 26;55(6):848-54.

PMID:
10994007
17.

Multiple sclerosis--Part 2. Treatment strategies.

Olek MJ.

J Am Osteopath Assoc. 1999 Dec;99(12):611-9.

PMID:
10641492
18.

Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.

Hohol MJ, Olek MJ, Orav EJ, Stazzone L, Hafler DA, Khoury SJ, Dawson DM, Weiner HL.

Mult Scler. 1999 Dec;5(6):403-9.

PMID:
10618696
19.
20.

Geographic variation of MS incidence in two prospective studies of US women.

Hernán MA, Olek MJ, Ascherio A.

Neurology. 1999 Nov 10;53(8):1711-8.

PMID:
10563617
21.
22.

Seasonal variation of interferon-gamma production in progressive multiple sclerosis.

Balashov KE, Olek MJ, Smith DR, Khoury SJ, Weiner HL.

Ann Neurol. 1998 Nov;44(5):824-8.

PMID:
9818941
23.

Methotrexate in the treatment of multiple sclerosis.

Olek MJ, Hohol MJ, Weiner HL.

Ann Neurol. 1996 May;39(5):684. No abstract available.

PMID:
8619559
24.

Clonidine in the treatment of spasticity in patients with multiple sclerosis.

Khan OA, Olek MJ.

J Neurol. 1995 Oct;242(10):712-3. No abstract available.

PMID:
8568536
25.

Visually induced paroxysmal nausea and vomiting as presenting manifestations of multiple sclerosis.

Khan OA, Sandoz GM, Olek MJ, Kuta AJ.

J Neurol Neurosurg Psychiatry. 1995 Sep;59(3):342-3. No abstract available.

26.

Treatment of paroxysmal symptoms in multiple sclerosis with bromocriptine.

Khan OA, Olek MJ.

J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):253. No abstract available.

27.

Corticosteroids, optic neuritis, and multiple sclerosis.

Olek MJ, Khan OA.

N Engl J Med. 1994 Apr 28;330(17):1238; author reply 1239. No abstract available.

PMID:
8139643

Supplemental Content

Support Center